Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-16.27%
0%
-16.27%
6 Months
-25.18%
0%
-25.18%
1 Year
-39.02%
0%
-39.02%
2 Years
-45.05%
0%
-45.05%
3 Years
-60.19%
0%
-60.19%
4 Years
-66.72%
0%
-66.72%
5 Years
-63.75%
0%
-63.75%
ScandiDos AB for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
1.46%
EBIT Growth (5y)
14.43%
EBIT to Interest (avg)
-5.43
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
1.50
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.02%
ROE (avg)
0.15%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.53
EV to EBIT
-55.80
EV to EBITDA
42.34
EV to Capital Employed
1.68
EV to Sales
0.92
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1.22%
ROE (Latest)
-2.78%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Apr'25 - YoY
Apr'25
Apr'24
Change(%)
Net Sales
15.30
14.70
4.08%
Operating Profit (PBDIT) excl Other Income
0.70
-2.00
135.00%
Interest
0.30
0.40
-25.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.60
-7.60
92.11%
Operating Profit Margin (Excl OI)
16.70%
-533.90%
55.06%
USD in Million.
Net Sales
YoY Growth in quarter ended Apr 2025 is 4.08% vs -23.83% in Apr 2024
Consolidated Net Profit
YoY Growth in quarter ended Apr 2025 is 92.11% vs -445.45% in Apr 2024
Annual Results Snapshot (Consolidated) - Apr'25
Apr'25
Apr'24
Change(%)
Net Sales
61.80
60.40
2.32%
Operating Profit (PBDIT) excl Other Income
3.50
-8.10
143.21%
Interest
0.80
1.20
-33.33%
Exceptional Items
0.00
-5.30
100.00%
Consolidate Net Profit
0.30
-14.60
102.05%
Operating Profit Margin (Excl OI)
28.90%
-135.00%
16.39%
USD in Million.
Net Sales
YoY Growth in year ended Apr 2025 is 2.32% vs -1.79% in Apr 2024
Consolidated Net Profit
YoY Growth in year ended Apr 2025 is 102.05% vs -60.44% in Apr 2024
About ScandiDos AB 
ScandiDos AB
Software Products
ScandiDos AB is a Sweden-based company active within the medical equipment sector. The Company's competence includes the design and development of radiation detectors, electrometers and application software, as well as clinical experience in medical physics and radiation measurements. The Company's business focuses on developing such applications as Arc Therapy - IMAT/VMAT, Tomotherapy, IMRT and Machine QA, among others. ScandiDos AB markets its products under the Delta4 brand. Delta4 offers Delta4AT - At Treatment in-vivo dosimetry for advanced RT and Delta4PT - Pre Treatment volumetric plan QA, among others. It operates in Europe, Asia, North America and Asia, and through numerous distributors and subsidiaries, including Additec GmbH and Conmedica GmbH in Germany, and ScandiDos SAS in France.
Company Coordinates 
Company Details
Dag Hammarskjolds Vag 52 A , UPPSALA None : 752 37
Registrar Details






